Andrew Dudum

Andrew Dudum is the co-founder and chief executive officer of Hims & Hers Health Inc., a prominent U.S. telehealth provider. Under his leadership, the company has expanded its services internationally, recently acquiring the Canadian telehealth company Livewell to tap into the growing demand for affordable weight-loss medications such as semaglutide. Dudum emphasizes the importance of addressing the obesity crisis and aims to provide advanced therapies to Canadians, as the market for generic Ozempic is expected to open soon. His strategic vision involves using Canada as a model for future expansions into other global markets.